Dr. Wisniewski co-founded Profusa, Inc., a company that is revolutionizing continuous monitoring of body chemistries through in vivo biosensors and mobile health. Profusa has developed injectable sensors from concept to clinic, with landmark longevity of 4 years function the body. Dr. Wisniewski is the Principle Investigator on over $30M of NIH and DARPA grants, and has over 100 papers, patents and invited lectures on wearable devices, implantable sensors and metabolic monitoring. She was awarded the NIH Transformative Research Award for her work on mobile health monitoring. Profusa is recognized as a Frost and Sullivan Entrepreneurial Company of the Year and one of FierceMedTech’s 15 most promising private med tech companies.